-Biohaven Enrolls First Patient in Phase 3 Generalized Anxiety Disorder Trial of Troriluzole

Press/Media

Period21 Feb 2019

Media coverage

1

Media coverage

  • Title-Biohaven Enrolls First Patient in Phase 3 Generalized Anxiety Disorder Trial of Troriluzole
    Media name/outletENP Newswire
    Date21/02/19
    PersonsSanjay Mathew